AbCellera Biologics Inc. - Common Shares (NQ:ABCL)

13.38 -0.36 (-2.62%)

Delayed Quote Updated: 10:45 AM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AbCellera Biologics Inc. - Common Shares

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

AbCellera Announces Secondary Private Sale of 11.9 Million Common Shares

June 10, 2021

From AbCellera Biologics Inc.

Via Business Wire

The Daily Biotech Pulse: US To Procure 500M Pfizer-BioNTech Vaccine Doses For Donation, Verona Out-Licenses COPD Drug, Nautilus Lists Through SPAC Deal ↗

June 10, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 9) Aethlon Medical, Inc. (...

Via Benzinga

New New Deal Worries ↗

May 27, 2021

Nio is up 1.4% today on another round of Meme buying.

Via Talk Markets

The Surprising Move Vir Stock Made After Winning Covid Drug Authorization ↗

May 27, 2021

GlaxoSmithKline and Vir Biotechnology won Food and Drug Administration authorization for a Covid treatment on Wednesday, but Vir stock slipped Thursday.

Via Investor's Business Daily

60 Biggest Movers From Yesterday ↗

May 27, 2021

Gainers Lizhi Inc. (NASDAQ: LIZI) shares surged 57.6% to close at $6.84 on Wednesday. Flywire Corporation (NASDAQ: FLYW) gained 46.3% to settle at $35.10 after the company priced...

Via Benzinga

Sterling At Five-Year High ↗

May 25, 2021

Today markets are mixed because of currency factors, with sterling bullishness against the dollar and the euro.

Via Talk Markets

Worldwide Upbeat ↗

May 21, 2021

The US crackdown on cryptocurrencies continues with the Fed today indicating that an official crypto-currency is going to be created for the USA.

Via Talk Markets

Topics Economy

Another Tough Day For Markets ↗

May 17, 2021

The stock market resumed its negativism today mainly linked to fear of inflation and higher interest rates, on the argument that the most dangerous thing to believe is “it's different this time.”

Via Talk Markets

CORRECTING and REPLACING AbCellera Reports Q1 2021 Business Results

May 14, 2021

From AbCellera Biologics Inc.

Via Business Wire

Friday Of The Heavy Week ↗

May 14, 2021

There is nothing like a pending weekend to push Wall Street into recuperation and this worked today

Via Talk Markets

Why AbCellera Stock Crumbled Despite In-Line Royalties For Covid Drug ↗

May 14, 2021

AbCellera stock crumbled Friday after the company guided to lower royalties from Covid treatment partner Eli Lilly in the second quarter.

Via Investor's Business Daily

AbCellera Biologics Inc. (ABCL) Q1 2021 Earnings Call Transcript ↗

May 13, 2021

ABCL earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

AbCellera Reports Q1 2021 Business Results

May 13, 2021

From AbCellera Biologics Inc.

Via Business Wire

The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use ↗

May 13, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 12) Alexion Pharmaceuticals, Inc...

Via Benzinga

AbCellera to Present Virtually at Berenberg Conference on May 18, 2021

May 11, 2021

From AbCellera Biologics Inc.

Via Business Wire

AbCellera Partners with Angios to Develop Therapeutics to Combat Blindness Caused by Diabetic Retinopathy

May 06, 2021

From AbCellera Biologics Inc.

Via Business Wire

Finns and Danes ↗

May 05, 2021

Stock markets are still uncertain whether to rise or fall after the Tuesday debacle.

Via Talk Markets

Merry Month of May ↗

May 04, 2021

Today the unhinged markets of Monday went into normal mode as the rest of the world's markets re-opened.

Via Talk Markets

The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings ↗

May 09, 2021

Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came...

Via Benzinga

AbCellera-Lilly Partnered Second COVID-19 Antibody Enters Human Trials ↗

May 04, 2021

AbCellera Biologics Inc (NASDAQ: ABCL) has announced that a second antibody from its collaboration with Eli Lilly and Co (NYSE: LLY), LY-CoV1404, ...

Via Benzinga

New AbCellera-Discovered Antibody that Neutralizes Viral Variants of COVID-19, LY-CoV1404, Enters Clinical Trials

May 04, 2021

From AbCellera Biologics Inc.

Via Business Wire

22 Stocks Moving in Monday's Pre-Market Session ↗

May 03, 2021

Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) rose 58.3% to $78.90 in pre-market trading. Nicholas Jason Singer disclosed a 9.13% passive stake in Brooklyn...

Via Benzinga

AbCellera Breaks Ground on Global Headquarters in Vancouver and Expects to Hire Hundreds of Scientific and Tech Professionals

April 29, 2021

From AbCellera

Via Business Wire

Tuesday Market Report ↗

April 27, 2021

Swiss ABB gained 0.8% more today after it reported on its Q1 today, confirming the pre-announced data from earlier in April.

Via Talk Markets

London Cancel ↗

April 26, 2021

Brazilian Cosan is up 0.43% despite desperate Covid-19 outbreaks along the Amazon.

Via Talk Markets

Earth Day ↗

April 22, 2021

Once again the exchanges are unsure if they want to go up or down.

Via Talk Markets

AbCellera to Report First Quarter 2021 Financial Results on May 13, 2021

April 21, 2021

From AbCellera

Via Business Wire

AbCellera and Empirico Announce Strategic Multi-Target Antibody Discovery Collaboration

April 14, 2021

From AbCellera Biologics Inc.

Via Business Wire

The Daily Biotech Pulse: Merck Shelves 2 COVID-19 Studies, Bristol-Myers Squibb Gets European Regulatory Nod, InspireMD's Reverse Split ↗

April 15, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 14) 10x Genomics, Inc. (NASDAQ...

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.